AMETEK, Inc. · AME · FY2026 Q2 · Calendar Q3 2026

AMETEK Q2: Record Sales, Strong Orders and Higher Guidance

AMETEK's Q2 supports a constructive operating outlook: record sales, sharply higher orders, raised full-year guidance and demand tied to semiconductor, power, defense and MedTech markets. The main test is whether backlog conversion, organic growth and acquisition execution sustain that momentum.

Reported Before market openNYSEIndustrials $55.29B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $2.09 Consensus $1.99
EPS surprise +5.0% Reported versus consensus
Reported revenue $2.04B Consensus $1.95B
Revenue surprise +4.6% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +4.2% Event window
SPY move +1.8% Same window
Abnormal move +2.4% Stock minus SPY
Volume 2.5× Versus trailing sessions
Subsequent drift -8.9% Up to 20 sessions
AMESPY benchmark

Ask FN2 about AME FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior quarter, AMETEK reported stronger Q2 scale and orders, raised full-year targets to approximately 10% sales growth and $8.20-$8.30 EPS, and advanced the Indicor and FARO acquisition agenda. Management also introduced AI Wave 2 initiatives and reported new product vitality at 25%.

Guidance delta

Management raised full-year guidance, targeting approximately 10% sales growth and EPS of $8.20-$8.30.

Key takeaways

  • Q2 sales reached a record $2.04 billion, up 15% year over year.
  • Orders grew 28% to $4.11 billion, with approximately 80% of the backlog expected to ship within 12 months.
  • Management highlighted AI-driven semiconductor demand, power-grid build-out, defense modernization and MedTech as growth drivers.
  • Indicor and FARO add acquisition-related execution and synergy milestones to monitor.

Management priorities

  • Close the Indicor acquisition in the second half of 2026.
  • Integrate FARO with Creaform and pursue expected cost synergies.
  • Advance AI Wave 2 initiatives across functions and product lines.
  • Continue product development and maintain disciplined capital spending near 2% of sales.

Follow AME with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
AME EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q4 '23 estimate $1.63 Q4 '23 actual $1.68, beat Q1 '24 estimate $1.59 Q1 '24 actual $1.64, beat Q2 '24 estimate $1.64 Q2 '24 actual $1.66, beat Q3 '24 estimate $1.62 Q3 '24 actual $1.66, beat Q2 '25 estimate $1.69 Q2 '25 actual $1.78, beat Q3 '25 estimate $1.76 Q3 '25 actual $1.89, beat Q4 '25 estimate $1.94 Q4 '25 actual $2.01, beat Q1 '26 estimate $1.90 Q1 '26 actual $1.97, beat Q2 '26 estimate $1.99 Q2 '26 actual $2.09, beat Q3 '26 estimate $2.10 Q4 '26 estimate $2.14 Q1 '27 estimate $2.19
Show less

Analyst Consensus ?

ConsensusBuy29 ratings
Bullish1965.5%
Neutral1034.5%
Bearish00.0%

Analyst 52W Price Targets

$245.41Current
$135Low
$236.93Average
$316High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
BNP Paribas Outperform OutperformMaintainSep 11, 2026
Truist Securities Buy BuyMaintainAug 6, 2026
TD Cowen Buy BuyMaintainAug 6, 2026
RBC Capital Outperform OutperformMaintainAug 5, 2026
Keybanc Overweight OverweightMaintainAug 5, 2026
Show 24 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $245.41. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Vertical ResearchAnalyst unavailable$255$237.72 +3.9%Sep 8, 2026
Truist FinancialAnalyst unavailable$316$255.23 +28.8%Aug 6, 2026
Seaport GlobalScott Graham$290$255.81 +18.2%Aug 5, 2026
RBC CapitalDeane Dray$291$254.5 +18.6%Aug 5, 2026
Robert W. BairdQuinn Fredrickson$275$254.05 +12.1%Aug 5, 2026
See 48 more

Track every rating change on AME the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

AMETEK, Inc. is a global enterprise that develops and markets a diverse portfolio of electronic instruments and electromechanical devices. The company's operations are structured into two principal divisions: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). The EIG segment provides sophisticated instrumentation solutions catering to various sectors, including process control, aerospace, power generation, and general industrial applications. It also delivers specialized process and analytical tools essential for industries such as oil and gas, petrochemicals, pharmaceuticals, semiconductors, automation, and food and beverage production. Furthermore, EIG supplies equipment for laboratory settings, ultra-precision manufacturing, medical diagnostics, and critical test and measurement tasks.…

Historical context

All AME earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the AME recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-04T20:12:16.089167+00:00
  2. FN2 earnings calendar · 2026-09-09T01:23:14.388487+00:00
  3. Polygon adjusted daily market bars · 2026-09-23T00:40:54.870215+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T00:40:54.866991+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.